CAAS Capital Management’s Hims & Hers Health HIMS Stock Holding History

CAAS Capital Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$298K	Buy	+10,100	New	+$375K	0.03%	324

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

CAAS Capital Management's HIMS Position: Q1 2025 in Review

CAAS Capital Management opened a new position in Hims & Hers Health (HIMS) in Q1 2025: 10,100 shares worth $298K. The stake represents 0.03% of the portfolio and ranks #324 among its holdings.

429 funds tracked by Wall St. Rank hold HIMS as of Q1 2025.

CAAS Capital Management held 10,100 shares of Hims & Hers Health worth $298K as of Q1 2025.
Hims & Hers Health was a new CAAS Capital Management position in Q1 2025.
Hims & Hers Health made up 0.03% of CAAS Capital Management's portfolio in Q1 2025, its #324 holding.
429 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2025.

Based on CAAS Capital Management's 13F filing for Q1 2025, filed 1 May 2025.